1,344
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Short Report

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis

ORCID Icon, , , &
Article: 2097818 | Received 01 Mar 2022, Accepted 01 Jul 2022, Published online: 11 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.